Hepion Pharmaceuticals, Inc. announced that Dr. Robert Foster, the Company?s CEO, resigned from the Company as CEO and director for personal reasons, effective immediately. John Cavan, the Company?s CFO has been appointed as interim CEO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +6.20% | -31.84% | -57.72% |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
Apr. 22 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.72% | 7.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- HEPA Stock
- News Hepion Pharmaceuticals, Inc.
- Hepion Pharmaceuticals, Inc. Announces CEO Changes